We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
TIPRL potentiates survival of lung cancer by inducing autophagy through the eIF2α-ATF4 pathway.
- Authors
Jeon, Su-Jin; Ahn, Jun-Ho; Halder, Debasish; Cho, Hyun-Soo; Lim, Jung-Hwa; Jun, Soo Young; Lee, Jeong-Ju; Yoon, Ji-Yong; Choi, Min-Hyuk; Jung, Cho-Rok; Kim, Jin-Man; Kim, Nam-Soon
- Abstract
Autophagy, an intracellular system of degrading damaged organelles and misfolded proteins, is essential for cancer cell survival. Despite the progress made towards understanding the mechanism, identification of novel autophagy regulators presents a major obstacle in developing anticancer therapies. Here, we examine the association between the TOR signaling pathway regulator-like (TIPRL) protein and autophagy in malignant transformation of tumors. We show that TIPRL upregulation in non-small cell lung cancer (NSCLC) potentiated autophagy activity and enabled autophagic clearance of metabolic and cellular stress, conferring a survival advantage to cancer cells. Importantly, the interaction of TIPRL with eukaryotic initiation factor 2α (eIF2α) led to eIF2α phosphorylation and activation of the eIF2α-ATF4 pathway, thereby inducing autophagy. Conversely, TIPRL depletion increased apoptosis by reducing autophagic clearance, which was markedly enhanced in TIPRL-depleted A549 xenografts treated with 2-deoxy-D-glucose. Overall, the study indicated that TIPRL is a potential regulator of autophagy and an important drug target for lung cancer therapy.
- Publication
Cell Death & Disease, 2019, Vol 10, Issue 12, p1
- ISSN
2041-4889
- Publication type
Article
- DOI
10.1038/s41419-019-2190-0